Coordinatore | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
Organization address
address: 101 Rue de Tolbiac contact info |
Nazionalità Coordinatore | France [FR] |
Sito del progetto | http://www.neurodegenerationresearch.eu/about/jumpahead/ |
Totale costo | 2˙618˙089 € |
EC contributo | 2˙000˙000 € |
Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
Code Call | FP7-HEALTH-2010-single-stage |
Funding Scheme | CSA-CA |
Anno di inizio | 2010 |
Periodo (anno-mese-giorno) | 2010-09-01 - 2014-08-31 |
# | ||||
---|---|---|---|---|
1 |
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
Organization address
address: 101 Rue de Tolbiac contact info |
FR (PARIS) | coordinator | 68˙612.00 |
2 |
INSERM - TRANSFERT SA
Organization address
address: Rue Watt 7 contact info |
FR (PARIS) | participant | 581˙170.00 |
3 |
THE HEALTH RESEARCH BOARD
Organization address
address: LOWER BAGGOT STREET 73 contact info |
IE (DUBLIN) | participant | 489˙455.00 |
4 |
DEUTSCHES ZENTRUM FUER LUFT - UND RAUMFAHRT EV
Organization address
address: Linder Hoehe contact info |
DE (KOELN) | participant | 442˙217.00 |
5 |
MEDICAL RESEARCH COUNCIL
Organization address
address: NORTH STAR AVENUE POLARIS HOUSE contact info |
UK (SWINDON) | participant | 179˙634.00 |
6 |
THE NETHERLANDS ORGANISATION FOR HEALTH RESEARCH AND DEVELOPMENT
Organization address
address: Laan Van Nieuw Oost Indie 334 contact info |
NL (DEN HAAG) | participant | 140˙384.00 |
7 |
MINISTERO DELL'UNIVERSITA E DELLA RICERCA
Organization address
address: Via Michele Carcani 61 contact info |
IT (ROMA) | participant | 71˙904.00 |
8 |
TURKIYE BILIMSEL VE TEKNOLOJIK ARASTIRMA KURUMU
Organization address
address: Ataturk Bulvari 221 contact info |
TR (ANKARA) | participant | 26˙624.00 |
9 |
BUNDESMINISTERIUM FUER BILDUNG UND FORSCHUNG
Organization address
address: Heinemannstrasse 2 contact info |
DE (BONN) | participant | 0.00 |
10 |
INSTITUTO DE SALUD CARLOS III
Organization address
address: CALLE SINESIO DELGADO 4-6 contact info |
ES (MADRID) | participant | 0.00 |
11 |
Nemzeti Kutatasi, Fejlesztesi es Innovacios Hivatal
Organization address
address: ANDRASSY UT 12 contact info |
HU (BUDAPEST) | participant | 0.00 |
12 |
NEUROIMUNOLOGICKY USTAV SLOVENSKEJAKADEMIA VIED
Organization address
address: DUBRAVSKA CESTA 9 contact info |
SK (BRATISLAVA) | participant | 0.00 |
13 |
VETENSKAPSRADET - SWEDISH RESEARCH COUNCIL
Organization address
address: VASTRA JARNVAGSGATAN 3 contact info |
SE (STOCKHOLM) | participant | 0.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'The objective of the Coordination Action JUMPAHEAD is to support the implementation of the pilot Joint Programming Initiative on combating neurodegenerative diseases, in particular Alzheimer’s disease (JPND). Neurodegenerative disorders are incurable and debilitating conditions that result in progressive degeneration or death of nerve cells. Of these, the dementias are responsible for the greatest burden of disease, and today in Europe over 7 million people suffer from Alzheimer's disease and related disorders, with this figure expected to double by 2020 as the European population ages. Although our understanding of the mechanisms of neurodegenerative disease has greatly improved over the past few years, there is no effective treatment able to stop or even slow down the deterioration of brain functions associated with these disorders. To tackle this pan-European health and societal challenge more effectively, 22 EU countries have launched the JPND. This is an innovative programme based on a common vision to improve the impact of their combined research effort to accelerate progress towards new treatments, identify preventative strategies, and improve patient care. JUMPAHEAD will build the foundations for this initiative by supporting the development and implementation of a Strategic Research Agenda, as well as its dissemination and evaluation. This will be achieved under the direction of the JPND Management Board. The output of JUMPAHEAD over its 36 month duration will include innovative ways of pooling national expertise and resources and the establishment of closer and robust research collaborations among the participating States in the field of neuro-degeneration research. JUMPAHEAD will contribute to the European Research Area by addressing fragmentation and improving integration of national research programmes to offer a competitive and attractive image of European research prosecuted for the greatest benefit of Europe’s populations and economies.'
Millions of people in Europe alone suffer from neurodegenerative disorders such as Alzheimer's and Parkinson's disease. Concerted activities among EU countries are essential towards a more targeted translational research approach.
"Credits-based, people-centric approach for the adoption of healthy life-styles and balanced Mediterranean diet in the frame of social participation and innovation for health promotion."
Read MoreSearch for new therapeutic agents against complicated obesity by reprofiling existing drugs
Read More